Filed before 2025Filed 20 November 2024
Metsera, Inc. raised $215M
Metsera, Inc., a biotech company based in New York, NY, raised $215M in a new equity round, according to a filing dated 20 November 2024.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 20 November 2024
- Round
- Equity round
- Amount sold
- $215M
- Offering size
- $215M
- Investors so far
- 38
- Based in
- New York, NY
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
2 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 99% of the 1,434 tracked raises with an amount filed in 2024, and than 96% of the 138 in biotech.
Metsera, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 20 Nov 2024 | New filing | $215M | This raise |
More with ARCH on the board
- SonoThera, Inc.$125M
- Ollin Biosciences, Inc.$156M
- Vizgen, Inc.$47.8M
- Pheast Therapeutics, Inc.$24.6M
Other unannounced rounds
- Thoughtform, Inc.$6.6M
- ProvenAir Technologies, Inc.$488K
- Gravitics, Inc.$17M
- SurgiBox Inc.$486K
- Voxel Labs Inc.$10M
- DVx Atomic Co.$18.5M
Seen it announced?
Send the link and the check will look at it.